Company | SITC | Symbol |
Company Name | Sitara Chemical Industries Ltd. | Company Name |
Avg EPS | Rs 24.37 | Average of past year end EPS's |
Avg EPS FV | Rs 256.57 | Fair Value based on average of past year end EPS's |
EPS | Rs 41.53 | Last four quarters EPS |
EPS FV | Rs 437.16 | Fair Value based on last four quarters EPS |
Current Price | Rs 178.20 | Last closing stock price |
Updated | December 2012 | Data Month/Year |
Div | Rs 8.00 | Total dividend paid during last four quarters |
Div FV | Rs 84.21 | Fair value based on total dividend paid during last four quarters |
Avg Div | Rs 6.19 | Average of yearly dividends paid (including currently paid ones) |
Avg Div FV | Rs 65.20 | Fair value based on Average of yearly dividends paid (including currently paid ones) |
Avg | Rs 161.09 | Fair value (averaged of other fair value) |
Upside | -9.60% | Upside potential (in percentage) based on the above Average. |
Div Yield | 4.49% | Dividend yield |
Book Value | Rs 287.87 | Book Value |
Sector | Chemicals | Sector |
FV CF/S | Rs 176.83 | Fair Value based on cash flow per share |
Outstanding Shares | 21,429,524 | Number of Outstanding Shares |
Current Assets | Rs 3,107.00 | Currency in Millions of Pakistan Rupees |
Total Liabilities | Rs 6,969.00 | Currency in Millions of Pakistan Rupees |
NCAV/S | Rs -180.22 | Net Current Asset Value / Share |
Total Assets | Rs 13,138.00 | Currency in Millions of Pakistan Rupees |
Quarter | September 2012 | Data Quarter |
CfO | Rs 360.00 | CASH FROM OPERATIONS (Millions of Rs) |
CF/S | Rs 16.80 | Cash Flow per Share |
Symbol | SITC | |
Current Price | Rs 182.10 | |
Previous Day Price | Rs 174.86 | |
Daily Return | 4.14% | |
Price Week Ago | Rs 172.28 | |
Weekly Return | 5.70% | |
Price Month Ago | Rs 177.50 | |
Monthly Return | 2.59% | |
Price Quarter Ago | Rs 142.55 | |
Quarterly Return | 27.74% | |
Price Year Ago | Rs 74.16 | |
Yearly Return | 145.55% |
Friday, December 21, 2012
SITC - Sitara Chemical Industries Ltd. - Analysis - 21/12/2012
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment